Bibliothèque CREDIMI
Résultat de la recherche
2 recherche sur le mot-clé 'USA'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Interroger des sources externes
Extraterritorial / Armand L. C. de MESTRAL
Réservation
Réserver ce document
Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité 1780 IV 1990 MES Livre CREDIMI 301 IV - Droit comparé et droits étrangers Disponible Regulation, Innovation and Competition in Pharmaceutical Markets / Margherita COLANGELO
Titre : Regulation, Innovation and Competition in Pharmaceutical Markets : A Comparative Study Type de document : texte imprimé Auteurs : Margherita COLANGELO, Auteur Editeur : Hart Publishing Année de publication : 2023 Collection : Hart Studies in Law and Health Importance : 256 pages Format : Relié ISBN/ISSN/EAN : 978-1-5099-6551-9 Langues : Français (fre) Catégories : Droit comparé et droits étrangers
Droit de la santé, droit pharmaceutique, droit de la personne et du corps humain
Droit économique, droit du marchéMots-clés : droit pharmaceutique propriété intellectuelle médicament laboratoires pharmaceutiques marché pharmaceutique antitrust concurrence droit comparé Union Européenne USA patent brevet santé publique droit de la concurrence industrie pharmaceutique pratiques anticoncurrentielles Résumé : This book explores the fundamental and inextricable relationship between regulation, intellectual property, competition law, and public health in pharmaceutical markets, examining their interconnections and the delicate balance between the various interests and policy goals at stake.
Although pharmaceutical markets are heavily regulated and subject to close antitrust scrutiny, there is a constant requirement for existing rules and policies to tackle a number of persistent, complex issues. The variety of anti-competitive practices occurring in this sector, the worrying rise in drug prices, and major, far-reaching concerns over the accessibility of medicines are sources of frequent controversy in academic and policy debates. Understanding the unique features and dynamics of the pharmaceutical industry requires a tailored and multifaceted approach.
The study is enhanced by the adoption of a comparative perspective, tracing convergence and divergence between EU and US systems through the analysis of relevant applicable rules, significant cases, and policy choices. Pursuant to this rigorous approach, the book provides an original and thought-provoking critique of the challenges of regulating pharmaceutical markets.Regulation, Innovation and Competition in Pharmaceutical Markets : A Comparative Study [texte imprimé] / Margherita COLANGELO, Auteur . - Hart Publishing, 2023 . - 256 pages ; Relié. - (Hart Studies in Law and Health) .
ISBN : 978-1-5099-6551-9
Langues : Français (fre)
Catégories : Droit comparé et droits étrangers
Droit de la santé, droit pharmaceutique, droit de la personne et du corps humain
Droit économique, droit du marchéMots-clés : droit pharmaceutique propriété intellectuelle médicament laboratoires pharmaceutiques marché pharmaceutique antitrust concurrence droit comparé Union Européenne USA patent brevet santé publique droit de la concurrence industrie pharmaceutique pratiques anticoncurrentielles Résumé : This book explores the fundamental and inextricable relationship between regulation, intellectual property, competition law, and public health in pharmaceutical markets, examining their interconnections and the delicate balance between the various interests and policy goals at stake.
Although pharmaceutical markets are heavily regulated and subject to close antitrust scrutiny, there is a constant requirement for existing rules and policies to tackle a number of persistent, complex issues. The variety of anti-competitive practices occurring in this sector, the worrying rise in drug prices, and major, far-reaching concerns over the accessibility of medicines are sources of frequent controversy in academic and policy debates. Understanding the unique features and dynamics of the pharmaceutical industry requires a tailored and multifaceted approach.
The study is enhanced by the adoption of a comparative perspective, tracing convergence and divergence between EU and US systems through the analysis of relevant applicable rules, significant cases, and policy choices. Pursuant to this rigorous approach, the book provides an original and thought-provoking critique of the challenges of regulating pharmaceutical markets.Réservation
Réserver ce document
Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité 3029 XXV 2023 COL Livre CREDIMI 301 XXV - Droit de la santé, pharmaceutique, de la personne et du corps humain Disponible